证券代码：000990 证券简称：诚志股份 公告编号：2025-030 诚志股份有限公司 公司于 2025 年 6 月 11-12 日发行了 2025 年度第一期中期票据,发行金额为 5 亿元，募集资金已于 2025 年 6 月 13 日到账。现将发行结果公告如下： | | 诚志股份有限公司 | | | | --- | --- | --- | --- | | 债券名称 | 2025 年度第一期中 | 债券简称 | 25诚志股份MTN001 | | | 期票据 | | | | 债券代码 | 102582393 | 期 限 | 3 年 | | 起息日 | 2025 年 06 月 13 日 | 兑付日 | 2028 年 06 月 13 日 | | 计划发行总额 | 50,000 | 实际发行总额 | 50,000 | | （万元） | | （万元） | | | 2.84 | 发行利率（%） | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | （2025 | | 年 | 6 | 月 | 13 | 日 | 发 ...

Core Viewpoint - The expansion of the consumption tax on refined oil products has led to significant tax liabilities for companies, highlighting the need for clarity on which products fall under the tax scope to mitigate tax risks [1][2]. Group 1: Tax Incidents - Two listed companies, Chengzhi Co., Ltd. and Ningbo Bohui Chemical Technology Co., Ltd., have faced substantial tax payments exceeding 100 million yuan due to the recent expansion of the consumption tax scope [1]. - Chengzhi's subsidiary was required to pay approximately 166 million yuan in consumption tax and related penalties, while Bohui reported a total of about 479 million yuan in tax payments [1][2]. Group 2: Regulatory Changes - In June 2023, the Ministry of Finance and the State Taxation Administration issued an announcement that effectively broadened the consumption tax scope for refined oil products, including mixed aromatics and heavy aromatics [2]. - The announcement aims to enhance tax management and promote the healthy development of the refined oil industry, with different tax rates applied to various oil products [2]. Group 3: Disputes and Clarifications - There are disputes between companies and tax authorities regarding whether certain products fall under the consumption tax scope, as seen in Bohui's case where the tax authority classified its heavy aromatic derivatives as taxable [3][4]. - The complexity arises from the diverse nature of chemical products and the potential for tax evasion through product name changes [4]. Group 4: Risk Mitigation Strategies - Companies are advised to assess their products against national and industry standards to determine tax obligations, as outlined by the State Taxation Administration [5]. - The administration has also introduced a temporary management method for testing taxable refined oil products to standardize the detection process and resolve disputes [6]. Group 5: Future Tax Reforms - The government plans to accelerate the reform of the consumption tax system, potentially moving the tax collection process to local levels, which could alleviate financial pressure on production enterprises [6][9]. - Experts suggest that moving the tax collection process could improve local government engagement in tax management, although it may also increase the administrative burden on tax authorities due to a larger number of taxpayers [9].

证券代码：000990 证券简称：诚志股份 公告编号：2025-029 诚志股份有限公司 关于子公司南京诚志为诚志永清提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 诚志股份有限公司（以下简称"公司"）第八届董事会第十一次会议和公司2024年年 度股东大会审议通过了《关于子公司南京诚志2025年度为诚志永清及诚志新材料提供担 保的议案》，具体内容详见公司于2025年3月27日披露的《关于为控股子公司提供担保的 公告》（公告编号：2025-013）。现就公司全资子公司南京诚志清洁能源有限公司（以下 简称"南京诚志"）为其全资子公司南京诚志永清能源科技有限公司（以下简称"诚志永 清"）提供担保相关事项的进展情况公告如下： 一、担保情况概述 2025年5月30日，南京诚志与交通银行股份有限公司江苏省分行签订了《保证合同》， 为诚志永清向交通银行股份有限公司江苏省分行申请的流动资金贷款提供担保，担保的 债权额度为人民币20,000万元。 二、担保协议的主要内容 保证人：南京诚志清洁能源有限公司 债权人：交通银行股份有限公司江苏省分行 债务人：南京诚 ...

证券代码：000990 证券简称：诚志股份 公告编号：2025-027 司 2024 年度利润分配预案的议案》。具体方案如下：公司以 2024 年 12 月 31 日 的总股本 1,215,237,535 股为基数，向全体股东每 10 股派发人民币现金红利 0.50 元（含税）。 总额在权益分派实施前发生变化，公司将按照分配总额不变的原则进行调整。 二、权益分派方案 公司 2024 年年度权益分派方案为：以公司现有总股本 1,215,237,535 股为 基数，向全体股东每 10 股派 0.500000 元人民币现金（含税；扣税后，通过深 股通持有股份的香港市场投资者、境外机构（含 QFII、RQFII）以及持有首发 前限售股的个人和证券投资基金每 10 股派 0.450000 元；持有首发后限售股、 股权激励限售股及无限售流通股的个人股息红利税实行差别化税率征收，公司 暂不扣缴个人所得税，待个人转让股票时，根据其持股期限计算应纳税额 【注】；持有首发后限售股、股权激励限售股及无限售流通股的证券投资基金 所涉红利税，对香港投资者持有基金份额部分按 10%征收，对内地投资者持有 基金份额部分实行差别化税率征收） ...

证券代码：000990 证券简称：诚志股份 公告编号：2025-027 诚志股份有限公司 2024年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 诚志股份有限公司（以下简称"公司"）2024 年年度权益分派方案已经公司 于 2025 年 4 月 16 日召开的 2024 年年度股东大会审议通过，现将权益分派事宜 公告如下： 一、股东大会审议通过利润分配方案的情况 1、2025 年 4 月 16 日，公司召开 2024 年年度股东大会审议通过了《关于公 司 2024 年度利润分配预案的议案》。具体方案如下：公司以 2024 年 12 月 31 日 的总股本 1,215,237,535 股为基数，向全体股东每 10 股派发人民币现金红利 0.50 元（含税）。 2、自本次分配方案披露至实施期间公司股本总额未发生变化。若公司股本 总额在权益分派实施前发生变化，公司将按照分配总额不变的原则进行调整。 3、本次实施的分配方案与股东大会审议通过的分配方案一致。 4、本次实施分配方案距离股东大会审议通过的时间未超过两个月。 二、权益分派方案 公司 2 ...

Core Viewpoint - Chengzhi Co., Ltd. announced that its subsidiary, Nanjing Chengzhi Yongqing Energy Technology Co., Ltd., is required to pay a total of 166 million yuan in taxes and penalties, which is expected to impact the company's net profit for 2025 by approximately 132 million yuan [1]. Group 1 - Chengzhi Yongqing received a tax notice from the Nanjing Taxation Bureau regarding the payment of consumption tax, tax surcharges, and related late fees for its carbon five heavy hydrocarbon products [1]. - The total amount to be paid by Chengzhi Yongqing is 166 million yuan, which has already been fully paid as of the announcement date [1]. - The estimated impact on the company's net profit for the year 2025 is around 132 million yuan, subject to final confirmation by the annual audit [1].

证券代码：000990 证券简称：诚志股份 公告编号：2025-028 诚志股份有限公司（以下简称"公司"）控股子公司南京诚志永清能源科技 有限公司（以下简称"诚志永清"）于近期收到国家税务总局南京市税务局稽查 局《税务事项通知书》（宁税稽税通[2025]20 号）（以下简称《通知书》）， 并就《通知书》相关内容进行了自查以及税款补缴，现将有关事项公告如下： 一、自查及税款补缴情况 经自查，诚志永清需对碳五重质烃产品补缴消费税、税金附加及相关滞纳金， 总金额共计 16,635.20 万元。截至本公告披露日，诚志永清已完成相关款项的 全额缴纳，当地主管税务部门未对该事项给予处罚。 二、对公司的影响 依据《企业会计准则》的相关规定，子公司诚志永清补缴的上述款项不属于 前期会计差错，不涉及前期财务数据追溯调整，预计影响公司 2025 年度净利润 约 13,222.86 万元。最终结果及影响金额以年审会计师审计后的数据为准。敬请 广大投资者注意投资风险。 特此公告。 诚志股份有限公司 董事会 2025 年 5 月 30 日 诚志股份有限公司 关于子公司收到《税务事项通知书》暨补缴税款的公告 本公司及董事会全体成员保证 ...

Core Viewpoint - Chengzhi Co., Ltd. (000990) announced that its subsidiary, Nanjing Chengzhi Yongqing Energy Technology Co., Ltd., has received a tax notice requiring the payment of consumption tax, tax surcharges, and related late fees totaling 166 million yuan [1] Group 1 - The total amount to be paid includes consumption tax on carbon five heavy hydrocarbons, tax surcharges, and related late fees [1] - Chengzhi Yongqing has completed the full payment of the required amount, and the local tax authority has not imposed any penalties [1] - The expected impact on the company's net profit for the year 2025 is approximately 132 million yuan [1]

Core Insights - The NHNE China International Health Nutrition Expo held in Guangzhou from May 21 to 23, 2025, attracted over 1,200 participating companies and more than 100,000 professional attendees [1] - The product "Libos® D-Ribose Powder" by Chengzhi Life Science Technology Co., Ltd. is the first approved health food in China featuring D-Ribose as the main active ingredient, known for its dual functions of anti-fatigue and hypoxia resistance, and is making significant changes in cardiac protection [1][3] Company Development - Chengzhi Life Science Technology Co., Ltd. has been tracking nearly 300,000 effective data points in China, showing that D-Ribose improves various cardiac symptoms [6] - The company has established collaborations with Tsinghua University and Beijing Sport University to conduct clinical studies on D-Ribose's application in athletics, demonstrating its benefits in enhancing anaerobic thresholds and reducing muscle damage markers [8] - The brand "Libos" was recently recognized as the leading brand in D-Ribose products in China, with a brand awareness rate of 98.12% [8][9] Market Performance - In 2024, sales of Libos® D-Ribose Powder increased by approximately 50%, with single product sales exceeding 100 million yuan, making it a standout in its category [9] - The company has shifted its strategy from being a raw material supplier to actively engaging with consumers and promoting brand recognition [11] Industry Trends - Cardiovascular diseases remain the leading cause of death globally, with the number of deaths rising from 270 million to 540 million over the past 30 years [13] - Chengzhi Life Science aims to focus on nutritional intervention for cardiovascular disease management, leveraging D-Ribose's role in energy metabolism and mitochondrial protection [15][16] Future Strategy - The company plans to enhance brand building and develop new health products with clear mechanisms of action and sufficient clinical research to contribute to the Healthy China 2030 initiative [17]

Core Viewpoint - The company is transitioning from its initial phase of basic chemical production to a more advanced stage focused on optimizing core industries and enhancing specialized industrial chains through its "One Body, Two Wings" strategy [2][3][6]. Group 1: Project Developments - The new integrated propylene value chain project was completed in just over eight months, marking it as a significant project in Nanjing Jiangbei New Area with an investment of over 1 billion yuan [2][5]. - The project utilizes advanced international technology, producing propylene from self-sourced materials and combining it with syngas and hydrogen to manufacture octanol [5][6]. - The project achieved successful trial production and sold 80 tons of octanol on the same day, demonstrating rapid recovery of investment [5][6]. Group 2: Financial Performance - In 2021, the company's net profit reached 1.008 billion yuan, a 184.01% increase year-on-year, but fell sharply to 52.9 million yuan in 2022 due to geopolitical issues affecting coal supply and prices [3][4]. - The company aims to maintain positive cash flow and inject new growth into its operations through early revenue-generating projects like the octanol production [7][12]. Group 3: Strategic Direction - The "One Body, Two Wings" strategy encompasses clean energy and high-end chemical materials, with a focus on technological innovation and extending the industrial chain [8][9]. - The company is exploring new markets in high-performance materials, including ultra-high molecular weight polyethylene (UHMWPE) and polyolefin elastomers (POE) [7][8]. - Collaboration with academic institutions aims to enhance capabilities in synthetic biology, targeting new product development and market expansion [10][11]. Group 4: Operational Enhancements - The company is restructuring its management and talent strategy to support its upgraded operational capabilities, ensuring efficient project execution and production optimization [11][12]. - Emphasis is placed on flexible production techniques and digital management to adapt to market fluctuations and improve operational efficiency [12].